spacer
The Healthcare Sales & Marketing Network celebrates 28 years serving the medical sales & marketing community.Connecting Medical Sales Reps with MedTech/BioPharma Recruiters and Independent Reps with and New Product LinesConnecting Medical Sales Reps with MedTech/BioPharma Recruiters and Independent Reps with and New Product Lines

Searching News Database:  embolic 


 Your search returned too many results! The most recent 500 items are shown below:
 HSMN NewsFeed - 10 Mar 2026
Medtronic to Acquire Scientia Vascular, Marrying Access and Therapeutic Portfolios for Neurovascular Care
Devices Interventional Mergers & Acquisitions
 HSMN NewsFeed - 10 Feb 2026
Vesalio Expands International Neurovascular Portfolio with CE Mark of NeVa VS and NeVa 3.0 mm and Receives Additional FDA 510(k) Clearance for its Aspiration Catheters
Devices Neurology Interventional Regulatory
 HSMN NewsFeed - 11 Dec 2025
Vesalio Receives FDA 510(k) Clearance of enVast, the First Stent-Based Coronary Thrombectomy Technology
Devices Interventional Cardiology FDA
 HSMN NewsFeed - 5 Aug 2025
Instylla Appoints MedTech Leader Sean Boyle as Chief Executive Officer
Devices Interventional Personnel
 HSMN NewsFeed - 20 Aug 2024
RYBREVANT(R) (amivantamab-vmjw) Plus LAZCLUZE(TM) (lazertinib) Approved in the U.S. as a First-line Chemotherapy-free Treatment for Patients with EGFR-mutated Advanced Lung Cancer
Biopharmaceuticals Oncology FDA
 HSMN NewsFeed - 21 May 2024
Biocon Biologics Obtains U.S. FDA Approval for Biosimilar Aflibercept for Yesafili(TM). Enters U.S. Ophthalmology Market
Biopharmaceuticals Generics Ophthalmology FDA
 HSMN NewsFeed - 12 Mar 2024
Emboline Announces That the First One Hundred Patients Have Been Treated in the IDE Study of the Emboliner(R) Full-Body Embolic Protection Catheter to Minimize Stroke Risk From TAVR
Devices Interventional Cardiology
 HSMN NewsFeed - 5 Dec 2023
ABK Biomedical Announces That its Eye90 Microspheres(R) Device Has Been Granted Breakthrough Device Designation by the U.S. Food and Drug Administration (FDA)
Devices Oncology FDA
 HSMN NewsFeed - 15 Aug 2023
Instylla Announces Completion of $30MM EQUITY Financing
Devices Interventional Venture Capital
 HSMN NewsFeed - 6 Jan 2023
Aeglea BioTherapeutics Announces Update to Corporate Structure to Increase Operational Efficiency
Biopharmaceuticals Personnel
 HSMN NewsFeed - 30 Nov 2022
Aeglea BioTherapeutics Appoints Jeffrey M. Goldberg as Chief Executive Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 23 Nov 2022
BioMarin Announces Advancements in FDA Review of ROCTAVIAN(TM) (Valoctocogene Roxaparvovec) for Adults with Severe Hemophilia A
Biopharmaceuticals FDA
 HSMN NewsFeed - 2 Nov 2022
'Enhanced Lung Rest' with CytoSorb and ECMO Achieves High Survival in 100 Critically Ill COVID-19 Patients with Refractory Lung Failure from Five Major U.S. Hospitals
Devices
 HSMN NewsFeed - 21 Oct 2022
Regeneron Receives Six Months of U.S. Pediatric Exclusivity for EYLEA(R) (aflibercept) Injection
Biopharmaceuticals Ophthalmology FDA
 HSMN NewsFeed - 26 Sep 2022
Innocoll and DURECT Announce U.S. launch of POSIMIR(R)
Biopharmaceuticals Drug Delivery Product Launch
 HSMN NewsFeed - 24 Aug 2022
Aeglea BioTherapeutics Announces Leadership Transition and Corporate Restructuring
Biopharmaceuticals Personnel
 HSMN NewsFeed - 15 Aug 2022
Boston Scientific Announces Acquisition of Obsidio, Inc.
Devices Interventional Mergers & Acquisitions
 HSMN NewsFeed - 10 Aug 2022
New Embolic Device Demonstrates Superior Vessel Filling in Tumor Models
Devices Interventional
 HSMN NewsFeed - 11 Jul 2022
Anthos Therapeutics Announces that Abelacimab has Received FDA Fast Track Designation for the Treatment of Thrombosis Associated with Cancer
Biopharmaceuticals FDA
 HSMN NewsFeed - 24 Jun 2022
BioMarin Receives Positive CHMP Opinion in Europe for Valoctocogene Roxaparvovec Gene Therapy to Treat Adults with Severe Hemophilia A
Biopharmaceuticals Regulatory
 HSMN NewsFeed - 21 Apr 2022
Wallaby Acquires German Neurovascular Leader Phenox to Accelerate Global Expansion
Devices Interventional Acquisitions
 HSMN NewsFeed - 18 Mar 2022
Venus Medtech appoints Shakeel Osman as Senior VP of Sales Europe to drive commercialization of TPVR system
Devices Interventional Cardiology Personnel
 HSMN NewsFeed - 9 Mar 2022
Metastatic Tumor Treatment with Novel GPX Embolic Device
Devices Interventional Oncology
 HSMN NewsFeed - 2 Feb 2022
Fluidx Medical's Embolic Demonstrates Novel Visibility Advantage
Devices Interventional
 HSMN NewsFeed - 20 Jan 2022
GPX Embolic Device Success in Challenging Tumor Case
Devices Interventional
 HSMN NewsFeed - 1 Dec 2021
Fluidx Medical Technology Announces Series A Led by Multinational Strategic Investor
Devices Venture Capital
 HSMN NewsFeed - 13 Oct 2021
FDA Approves Verzenio(R) (abemaciclib) as the First and Only CDK4/6 Inhibitor for Certain People with HR+ HER2- High Risk Early Breast Cancer
Biopharmaceuticals Oncology FDA
 HSMN NewsFeed - 3 Aug 2021
Lilly and Incyte's baricitinib reduced deaths among patients with COVID-19 receiving invasive mechanical ventilation
Biopharmaceuticals
 HSMN NewsFeed - 20 Apr 2021
Lilly and Incyte's Baricitinib Improved Hair Regrowth for Alopecia Areata Patients in Second Phase 3 Study
Biopharmaceuticals
 HSMN NewsFeed - 17 Mar 2021
Next-Generation Microcatheter Platform Earns CE Mark Approval
Devices Interventional Regulatory
 HSMN NewsFeed - 24 Feb 2021
Clarus Therapeutics Appoints Richard 'Ric' Peterson as Chief Financial Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 2 Feb 2021
DURECT Corporation Announces U.S. FDA Approval of POSIMIR(R) For Post-Surgical Pain Reduction for up to 72 Hours Following Arthroscopic Subacromial Decompression
Biopharmaceuticals Drug Delivery FDA
 HSMN NewsFeed - 2 Feb 2021
Novel Embolic Device Used for Arterial and Venous Tumor Treatments
Devices Interventional
 HSMN NewsFeed - 9 Dec 2020
Sirtex Medical announces strategic investment in BlackSwan Vascular, Inc.
Devices Oncology Venture Capital
 HSMN NewsFeed - 24 Nov 2020
New Embolic Device Used in Interventional Oncology for Highly Targeted Tumor Treatment
Devices Interventional Oncology
 HSMN NewsFeed - 17 Nov 2020
Boston Scientific Announces LOTUS Edge(TM) Aortic Valve System Voluntary Recall and Product Discontinuation
Devices Interventional Cardiology Product Recall
 HSMN NewsFeed - 16 Jun 2020
Keystone Heart, A Venus Medtech Company, Acquires 510 Kardiac Devices, Inc.
Devices Interventional Cardiology Mergers & Acquisitions
 HSMN NewsFeed - 12 May 2020
FDA Clears New XO Cross Microcatheter Platform
Devices Interventional FDA
 HSMN NewsFeed - 6 Apr 2020
HEMA Biologics(TM) Announces FDA Approval of SEVENFACT(R) [coagulation factor VIIa (recombinant)-jncw] for Treatment and Control of Bleeding Episodes Occurring in Adult and Adolescent Hemophilia A and B Patients with Inhibitors
Biopharmaceuticals FDA
 HSMN NewsFeed - 2 Apr 2020
Boston Scientific Provides Update on COVID-19 Impact and Response Efforts
Devices
 HSMN NewsFeed - 10 Mar 2020
TriGUARD 3(TM) Cerebral Embolic Protection Device Receives CE Mark for Use in Transcatheter Heart Procedures
Devices Interventional Cardiology Regulatory
 HSMN NewsFeed - 21 Feb 2020
Cerus Endovascular Successfully Completes Series B Financing and Receives U.S. FDA Approval for its First Microcatheter
Devices Interventional Neurology Venture Capital FDA
 HSMN NewsFeed - 20 Jan 2020
Varian Appoints Prof. Dr. Ricky Sharma VP of Clinical Affairs
Devices Oncology Personnel
 HSMN NewsFeed - 18 Oct 2019
Nplate(R) (romiplostim) Now Approved For Earlier Use In Adults With Immune Thrombocytopenia
Biopharmaceuticals FDA
 HSMN NewsFeed - 19 Aug 2019
Boston Scientific Closes Acquisition of BTG plc.
Devices Interventional Oncology Mergers & Acquisitions
 HSMN NewsFeed - 13 Aug 2019
FDA Approves EYLEA(R) (aflibercept) Injection Prefilled Syringe
Biopharmaceuticals Drug Delivery Ophthalmology FDA
 HSMN NewsFeed - 30 Jul 2019
Lilly's Verzenio(R) (abemaciclib) Significantly Extended Life in Women with HR+, HER2- Advanced Breast Cancer in MONARCH 2
Biopharmaceuticals Oncology
 HSMN NewsFeed - 2 Jul 2019
Varian to Expand Interventional Oncology Portfolio with Purchase of Embolic Bead Asset
Devices Interventional Acquisitions
 HSMN NewsFeed - 26 Dec 2018
Venus Medtech Completes Merger with Keystone Heart, Ltd.
Devices Interventional Cardiology Mergers & Acquisitions
 HSMN NewsFeed - 18 Dec 2018
Lilly Announces Publication of Analyses Showing Benefit of the Addition of Verzenio(R) (Abemaciclib) in Multiple Subgroups of Patients with Advanced Breast Cancer Identified as Having a More Concerning Prognosis
Biopharmaceuticals Oncology
 HSMN NewsFeed - 7 Dec 2018
Contego Medical Receives 510(k) Clearance for the Vanguard IEP Peripheral Angioplasty System with Integrated Embolic Protection
Devices Interventional FDA
 HSMN NewsFeed - 29 Nov 2018
FDA Accepts Filing of New Estrogen-free Oral Contraceptive Developed by Exeltis
Biopharmaceuticals FDA
 HSMN NewsFeed - 25 Oct 2018
EYLEA(R) (aflibercept) Injection Improves Diabetic Retinopathy and Reduces Vision-Threatening Complications in Phase 3 Trial
Biopharmaceuticals Ophthalmology
 HSMN NewsFeed - 23 Oct 2018
Duchesnay Inc. Announces Submission of Supplemental New Drug Application (sNDA) for Osphena(R) (ospemifene) to U.S. FDA Seeking Approval for the Treatment of Vaginal Dryness, a Symptom of Vulvar and Vaginal Atrophy (VVA) Due to Menopause
Biopharmaceuticals FDA
 HSMN NewsFeed - 1 Oct 2018
FDA Approves KYPROLIS(R) (carfilzomib) Once-Weekly 70 mg/m2 In Combination With Dexamethasone (Kd70) For Patients With Relapsed Or Refractory Multiple Myeloma
Biopharmaceuticals Oncology FDA
 HSMN NewsFeed - 25 Sep 2018
Venus Medtech Announces Agreement to Acquire Keystone Heart, LTD
Devices Interventional Mergers & Acquisitions
 HSMN NewsFeed - 13 Sep 2018
FDA to Review EYLEA (aflibercept) Injection for the Treatment of Diabetic Retinopathy
Biopharmaceuticals Ophthalmology FDA
 HSMN NewsFeed - 3 Sep 2018
Cablivi(TM) (caplacizumab) approved in Europe for adults with acquired thrombotic thrombocytopenic purpura (aTTP)
Biopharmaceuticals Regulatory
 HSMN NewsFeed - 28 Aug 2018
Daiichi Sankyo Presents First Snapshot Analyses from Global ETNA-AF Programme of Oral, Once-daily LIXIANA(R) (edoxaban) in Patients with Nonvalvular Atrial Fibrillation in Routine Clinical Practice
Biopharmaceuticals
 HSMN NewsFeed - 17 Aug 2018
Eisai And Merck Announce FDA Approval Of LENVIMA(R) (lenvatinib) Capsules For First-Line Treatment Of Unresectable Hepatocellular Carcinoma (HCC)
Biopharmaceuticals Oncology FDA
 HSMN NewsFeed - 17 Aug 2018
FDA Approves EYLEA(R) (aflibercept) Injection sBLA in Wet Age-related Macular Degeneration
Biopharmaceuticals Ophthalmology FDA
 HSMN NewsFeed - 13 Aug 2018
New Analysis Identifies Patient Populations With Cancer-associated VTE Who Could Benefit From Treatment With Oral, Once-daily LIXIANA(R) (edoxaban)
Biopharmaceuticals
 HSMN NewsFeed - 3 Aug 2018
Boston Scientific Closes Acquisition of Claret Medical, Inc., Announces Positive Reimbursement Decision
Devices Interventional Acquisitions Reimbursement
 HSMN NewsFeed - 30 Jul 2018
ABK Biomedical Appoints Michael J. Mangano as President and Chief Executive Officer
Devices Oncology Personnel
 HSMN NewsFeed - 20 Jul 2018
Boston Scientific Announces Agreement to Acquire Claret Medical, Inc.
Devices Interventional Mergers & Acquisitions
 HSMN NewsFeed - 11 Jun 2018
Roche introduces first self-testing device for Warfarin monitoring with built in Bluetooth(R) technology
Devices Monitoring Product Launch
 HSMN NewsFeed - 9 May 2018
Adventus Ventures announces initial financing for several of its medical device portfolio companies
Devices Venture Capital
 HSMN NewsFeed - 8 May 2018
NRG(R) Transseptal Needle Associated with a 40% Lower Risk of Silent Cerebral Embolism
Devices Cardiology
 HSMN NewsFeed - 30 Apr 2018
Actelion Submits Supplemental New Drug Application to US FDA Seeking Approval of OPSUMIT(R) (macitentan) for the Treatment of Chronic Thromboembolic Pulmonary Hypertension (CTEPH)
Biopharmaceuticals FDA
 HSMN NewsFeed - 19 Apr 2018
Emboline, Inc. Completes Funding Of Over $10 Million
Devices Interventional Cardiology Venture Capital
 HSMN NewsFeed - 18 Apr 2018
Tetherex Pharmaceuticals, Inc. Completes $50M Series B Financing
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 16 Apr 2018
Apitope Announces Positive Results with Novel Treatment for Graves' Disease
Biopharmaceuticals
 HSMN NewsFeed - 19 Mar 2018
Mallinckrodt Completes Sale Of RECOTHROM(R) And PREVELEAK(R) To Baxter
Biopharmaceuticals Acquisitions
 HSMN NewsFeed - 7 Mar 2018
Contego Medical Announces the Start of Enrollment in the PERFORMANCE I Trial
Devices Interventional Cardiology
 HSMN NewsFeed - 1 Mar 2018
SUBLOCADE(TM) (Buprenorphine Extended-Release) is Now Available as First and Only Monthly Injectable Buprenorphine in the U.S. to Treat Patients with Moderate to Severe Opioid Use Disorder
Biopharmaceuticals FDA Product Launch
 HSMN NewsFeed - 19 Jan 2018
Independent Imaging Review Confirmed Positive Data from Primary Analysis of REFLECT Trial Evaluating Lenvatinib Compared to Sorafenib in Unresectable Hepatocellular Carcinoma
Biopharmaceuticals Oncology
 HSMN NewsFeed - 17 Jan 2018
Pharming Announces FDA Acceptance for Review of Supplemental Biologics License Application for RUCONEST(R) for Prophylaxis of Hereditary Angioedema Attacks
Biopharmaceuticals FDA
 HSMN NewsFeed - 11 Jan 2018
First Patient Enrolled in U.S. IDE Study To Evaluate the Potential of New Device To Reduce Stroke Risk in Atrial Fibrillation Patients
Devices Interventional Cardiology
 HSMN NewsFeed - 27 Nov 2017
Pharming Submits Supplemental Biologics License Application to FDA for RUCONEST(R) for Prophylaxis of Hereditary Angioedema Attacks
Biopharmaceuticals FDA
 HSMN NewsFeed - 13 Nov 2017
EMD Serono Receives FDA Approval for New GONAL-f(R) RFF Redi-ject(R) Pen
Biopharmaceuticals Drug Delivery FDA
 HSMN NewsFeed - 10 Nov 2017
Amgen Receives Positive CHMP Opinion To Expand Use Of Nplate(R) (romiplostim) In Pediatric Patients With Chronic Immune Thrombocytopenic Purpura
Biopharmaceuticals Regulatory
 HSMN NewsFeed - 10 Nov 2017
Amgen And Allergan Receive Positive CHMP Opinion For ABP 215 (Biosimilar Bevacizumab) For The Treatment Of Certain Types Of Cancer
Biopharmaceuticals Oncology Regulatory
 HSMN NewsFeed - 9 Nov 2017
Stryker Receives US FDA HDE Approval ror the Neuroform Atlas(TM) Stent System to Treat Wide Neck Aneurysms
Devices Interventional FDA
 HSMN NewsFeed - 12 Oct 2017
FDA Grants Priority Review for Potential New Indication for Lilly's Verzenio(TM) (abemaciclib) as Initial Treatment of Advanced Breast Cancer
Biopharmaceuticals Oncology FDA
 HSMN NewsFeed - 6 Sep 2017
Gardia Medical Demonstrates Enhanced Safety in Lower Extremity Interventions
Devices Interventional
 HSMN NewsFeed - 25 Jul 2017
HAEGARDA(R) (C1 Esterase Inhibitor Subcutaneous [Human]) Now Available in the United States for Patients with Hereditary Angioedema
Biopharmaceuticals Product Launch
 HSMN NewsFeed - 21 Jul 2017
CSL Behring Receives Orphan-Drug Exclusivity for HAEGARDA(R) (C1 Esterase Inhibitor Subcutaneous [Human])
Biopharmaceuticals FDA
 HSMN NewsFeed - 17 Jul 2017
CHMP Issues a Positive Opinion for Daiichi Sankyo's Once-Daily LIXIANA(R) (edoxaban) in Patients with Atrial Fibrillation Undergoing Cardioversion
Biopharmaceuticals Cardiology Regulatory
 HSMN NewsFeed - 31 May 2017
Lilly Announces Phase 3 RANGE Urothelial Cancer Trial of CYRAMZA(R) (ramucirumab) Met Primary Endpoint, Improving Progression-Free Survival
Biopharmaceuticals Oncology
 HSMN NewsFeed - 28 Apr 2017
Venus Medtech's TAVR Device Is Approved By CFDA, Creating A New Era Of Interventional Cardiology In China
Devices Interventional Cardiology Regulatory
 HSMN NewsFeed - 27 Apr 2017
Contego Medical Receives CE Mark for Vanguard IEP(TM) Peripheral Balloon Angioplasty System with Integrated Embolic Protection
Devices Interventional Regulatory
 HSMN NewsFeed - 2 Mar 2017
Keystone Heart and Venus Medtech Announce Partnership for Cerebral Embolic Protection with Transcatheter Heart Valve Systems (TAVR) in China and Key Asian Markets
Devices Interventional Cardiology
 HSMN NewsFeed - 22 Dec 2016
Genentech’s Emicizumab for Hemophilia A Meets Primary Endpoint in Phase III Study
Biopharmaceuticals
 HSMN NewsFeed - 8 Dec 2016
Pharming Announces Completion of Acquisition of All North American Commercialisation Rights for RUCONEST(R) From Valeant
Biopharmaceuticals Acquisitions
 HSMN NewsFeed - 26 Oct 2016
InspireMD Announces Appointment of Medical Device Industry Veteran Agustin Gago as Chief Commercial Officer
Devices Interventional Personnel
 HSMN NewsFeed - 19 Oct 2016
First Patient in Malaysia Receives TheraSphere(TM) Radioembolization Therapy
Devices Oncology
 HSMN NewsFeed - 17 Oct 2016
InspireMD Announces Independent Study Published in the Journal of Endovascular Therapy That Continues to Support the Clinical Benefit and Utility of the CGuard Embolic Prevention System
Devices Interventional
 HSMN NewsFeed - 14 Oct 2016
BTG and Mirada Medical Announce CE Mark Certification for Simplicit90Y(TM) Dosimetry Software in Europe
Devices Oncology Regulatory
 HSMN NewsFeed - 29 Sep 2016
Amgen And Arrowhead Pharmaceuticals Announce Two Cardiovascular Collaborations
Biopharmaceuticals Licensing
 HSMN NewsFeed - 14 Sep 2016
European Commission Approves CABOMETYX(TM) (cabozantinib) Tablets for the Treatment of Advanced Renal Cell Carcinoma Following VEGF-Targeted Therapy
Biopharmaceuticals Oncology Regulatory
 HSMN NewsFeed - 8 Sep 2016
Neuravi Announces European Launch of EmboTrap II Stent Retriever for the Treatment of Acute Stroke
Devices Neurology Interventional Product Launch
 HSMN NewsFeed - 12 Aug 2016
Cook Medical Issues Global Recall of Roadrunner(R) UniGlide(R) Hydrophilic Wire Guides Due to Raw Materials Issue
Devices Interventional Product Recall
 HSMN NewsFeed - 12 Aug 2016
Arrowhead Pharmaceuticals Closes $45 Million Private Offering
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 25 Jul 2016
Neuravi Selects Robert Colloton to Lead U.S. Commercialization of Innovative Stent Retriever
Devices Interventional Neurology Personnel
 HSMN NewsFeed - 4 Jul 2016
European Commission Approves Extended Indication For Amgen's Kyprolis(R) (Carfilzomib) For The Treatment Of Relapsed Multiple Myeloma Patients
Biopharmaceuticals Oncology Regulatory
 HSMN NewsFeed - 1 Jul 2016
InspireMD Announces Pricing of Public Offering of Approximately $14.6 Million
Devices Interventional
 HSMN NewsFeed - 7 Jun 2016
InspireMD Names Dr. James Barry as President and CEO
Devices Interventional Personnel
 HSMN NewsFeed - 19 May 2016
TriGuard Cerebral Protection Device Shows Reduction in Stroke Rate and Improvement in Patients' Neurological Outcomes in TAVR Procedures
Devices Interventional Cardiology Neurology
 HSMN NewsFeed - 1 Apr 2016
BTG Announces US Launch of LC Bead LUMI(TM), Ground-Breaking Radiopaque Embolic Bead
Devices Interventional Product Launch
 HSMN NewsFeed - 12 Feb 2016
Sequent Medical Announces Initiation Of Study For The WEB Aneurysm Embolization System In Ruptured Aneurysms
Devices Neurosurgery Interventional Radiology
 HSMN NewsFeed - 3 Feb 2016
First Patient Treated With LC Bead LUMI(TM) Radiopaque Embolic Bead Supported by Philips Live Image Guidance
Devices Interventional Oncology Radiology
 HSMN NewsFeed - 1 Feb 2016
Mallinckrodt Completes Acquisition Of Three Commercial-Stage, Global Specialty Hemostasis Brands From The Medicines Company
Devices Surgery Acquisitions
 HSMN NewsFeed - 26 Jan 2016
Contego Medical Announces Positive Clinical Data for Paladin(R) System, the First Post-Dilation Balloon with Integrated Embolic Protection(TM) Technology
Devices Interventional
 HSMN NewsFeed - 22 Jan 2016
InspireMD Aligns Operations and Leadership Team, Appoints Isaac Blech as Vice Chairman of the Board
Devices Interventional Personnel
 HSMN NewsFeed - 14 Jan 2016
Contego Medical Announces European Commercialization of the Paladin(R) Carotid Post-Dilation Balloon with Integrated Embolic Protection(TM) Technology
Devices Interventional Product Launch
 HSMN NewsFeed - 21 Dec 2015
Oral REVLIMID(R) Plus Dexamethasone Granted Approval for Treatment of Patients with Newly Diagnosed Multiple Myeloma in Japan
Biopharmaceuticals Oncology Regulatory
 HSMN NewsFeed - 14 Dec 2015
BTG Announces FDA Clearance for LC Bead LUMI(TM), the First Commercially Available Radiopaque Embolic Bead in the US
Devices Interventional FDA
 HSMN NewsFeed - 3 Dec 2015
True North Therapeutics Announces $40 Million Series C Financing
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 2 Dec 2015
Surefire Medical Closes $15M Series C Financing Led by Tullis Health Investors
Devices Interventional Radiology Oncology Venture Capital
 HSMN NewsFeed - 10 Nov 2015
Boston Scientific To Acquire Interventional Radiology Business Of CeloNova Biosciences
Devices Interventional Radiology Oncology Acquisitions
 HSMN NewsFeed - 5 Nov 2015
Neuravi Announces First Patient Treated in International Pivotal Clinical Trial of Novel Stent Retriever for Acute Ischemic Stroke
Devices Neurosurgery Interventional
 HSMN NewsFeed - 25 Sep 2015
Surefire Medical Launches Advanced Precision Direct-To-Tumor Infusion System At CIRSE
Devices Interventional Oncology Product Launch
 HSMN NewsFeed - 24 Sep 2015
Pfizer’s Sayana(R) Press Becomes First Injectable Contraceptive In The United Kingdom Available For Administration By Self-Injection
Biopharmaceuticals Product Launch
 HSMN NewsFeed - 15 Sep 2015
Bellerophon Therapeutics Announces Leadership Team Changes
Devices Drug Delivery Personnel
 HSMN NewsFeed - 1 Sep 2015
Surefire Medical Receives FDA Clearance for Precision Direct-to-Tumor Embolization Device
Devices Drug Delivery Interventional Oncology FDA
 HSMN NewsFeed - 7 Aug 2015
NICE Recommends Once-daily Lixiana(R) (Edoxaban) for Preventing Stroke and Systemic Embolism in People with Non-valvular Atrial Fibrillation
Biopharmaceuticals Cardiology Regulatory
 HSMN NewsFeed - 29 Jul 2015
EMBA Medical(TM) Limited Awarded CE Certificate for Hourglass(TM) Peripheral Embolization Plug
Devices Interventional Regulatory
 HSMN NewsFeed - 2 Jul 2015
Galderma Receives FDA Approval to Market Restylane(R) Lyft with Lidocaine to Correct Age Related Volume Loss in the Cheek Area
Biopharmaceuticals Dermatology FDA
 HSMN NewsFeed - 17 Jun 2015
Neuravi Announces €19M ($21M) in Financing to Advance Innovative Minimally Invasive Stroke Therapy
Devices Neurology Interventional Venture Capital
 HSMN NewsFeed - 15 Apr 2015
InspireMD Announces Completion of Sales Restructuring Program
Devices Interventional Cardiology Distribution
 HSMN NewsFeed - 30 Mar 2015
The Medicines Company Receives European Commission Approval for Three Hospital Acute Care Products: KENGREXAL(TM) (cangrelor), ORBACTIV(R) (oritavancin) and RAPLIXA(TM) (sealant powder)
Biopharmaceuticals Regulatory
 HSMN NewsFeed - 23 Jan 2015
The Medicines Company Receives CHMP Positive Opinions for Three Hospital Acute Care Products: KENGREXAL(TM) (cangrelor), ORBACTIV(TM) (oritavancin) and RAPLIXA(TM) (sealant powder)
Biopharmaceuticals Regulatory
 HSMN NewsFeed - 12 Nov 2014
Beverly Huss Joins Surefire Medical Board of Directors
Devices Interventional Oncology Drug Delivery Personnel
 HSMN NewsFeed - 3 Nov 2014
Salix and Pharming Announce the Launch of RUCONEST(R) in the U.S. for the Treatment of Acute Angioedema Attacks in Patients with Hereditary Angioedema (HAE)
Biopharmaceuticals Product Launch
 HSMN NewsFeed - 17 Oct 2014
EYLEA(R) (aflibercept) Injection Demonstrates Significantly Greater Gains in Visual Acuity than Both Bevacizumab and Ranibizumab in NIH-Sponsored Diabetic Macular Edema Study
Biopharmaceuticals Ophthalmology
 HSMN NewsFeed - 16 Oct 2014
FDA Approves Boehringer Ingelheim's OFEV(R) (nintedanib) as First Kinase Inhibitor to Treat Idiopathic Pulmonary Fibrosis
Biopharmaceuticals FDA
 HSMN NewsFeed - 6 Oct 2014
Claret Medical Announces First Patient Treated in U.S. Pivotal Trial Evaluating Cerebral Protection During Transcatheter Aortic Valve Replacement (TAVR)
Devices Interventional Cardiology
 HSMN NewsFeed - 10 Sep 2014
Mylan to Acquire U.S. Rights to Arixtra(R) (fondaparinux sodium) Injection from Aspen
Biopharmaceuticals Generics
 HSMN NewsFeed - 8 Sep 2014
Prospective Clinical Data On Web Aneurysm Embolization System Demonstrate Excellent Safety And High Rate Of Stable Occlusion In Difficult To Treat Aneurysms
Devices Interventional Neurology
 HSMN NewsFeed - 27 Aug 2014
Ligand Partner GlaxoSmithKline Receives U.S. FDA Approval for Promacta(R)/Revolade(TM) For Use in Patients with Severe Aplastic Anemia
Biopharmaceuticals FDA
 HSMN NewsFeed - 17 Jul 2014
Salix and Pharming Announce FDA Approval of RUCONEST(R) for the Treatment of Acute Angioedema Attacks in Patients with Hereditary Angioedema (HAE)
Biopharmaceuticals FDA
 HSMN NewsFeed - 15 Jul 2014
InspireMD Appoints Dr. James Barry as Chief Operating Officer
Devices Interventional Personnel
 HSMN NewsFeed - 15 Jul 2014
Pradaxa(R) (dabigatran etexilate) Now Available in the UK for the Treatment of Deep Vein Thrombosis (DVT) and Pulmonary Embolism (PE) and Prevention of Recurrence
Biopharmaceuticals Regulatory
 HSMN NewsFeed - 15 Jul 2014
FDA Grants Genentech’s Avastin Priority Review for Certain Types of Cervical Cancer
Biopharmaceuticals Oncology FDA
 HSMN NewsFeed - 27 Jun 2014
EYLEA(R) (aflibercept) Injection Recommended for Approval for the Treatment of Visual Impairment due to Diabetic Macular Edema in the European Union
Biopharmaceuticals Ophthalmology Regulatory
 HSMN NewsFeed - 27 Jun 2014
Eliquis(R) (apixaban) Receives CHMP Positive Opinion for the Treatment of Deep Vein Thrombosis (DVT) and Pulmonary Embolism (PE), and Prevention of Recurrent DVT and PE
Biopharmaceuticals Regulatory
 HSMN NewsFeed - 13 Jun 2014
Ligand Partner GSK Announces Results of Phase 3 PETIT2 Study of Eltrombopag (Promacta(TM)/Revolade(TM)) in Pediatric Patients with Chronic Immune Thrombocytopenia
Biopharmaceuticals
 HSMN NewsFeed - 11 Jun 2014
Lilly Announces Top-Line Results Of Phase III Hepatocellular Carcinoma Trial
Biopharmaceuticals Oncology
 HSMN NewsFeed - 21 May 2014
Baxter Provides U.S. Regulatory Update on HyQvia, Its Investigational Subcutaneous Treatment for Primary Immunodeficiency
Biopharmaceuticals FDA
 HSMN NewsFeed - 20 May 2014
InspireMD to Showcase Embolic Systems with MicroNet(TM) Technology and Results from MASTER I Trial at EuroPCR Conference
Devices Interventional Cardiology
 HSMN NewsFeed - 30 Apr 2014
InspireMD Announces Voluntary Field Action for MGuard(TM) Prime EPS
Devices Interventional
 HSMN NewsFeed - 23 Apr 2014
Surefire Medical's Groundbreaking COSY Clinical Trial Results Presented at ECIO: Is Coiling Prior to Radioembolization Still Necessary in Minimally Invasive Treatment of Liver Cancer?
Devices Interventional Oncology
 HSMN NewsFeed - 11 Apr 2014
Covidien Implements Voluntary Recall of its Pipeline(TM) Embolization Device and Alligator(TM) Retrieval Device
Devices Product Recall
 HSMN NewsFeed - 31 Mar 2014
Daiichi Sankyo Initiates Phase 3 ENSURE-AF Study, Investigating Once-Daily Edoxaban in Patients with Atrial Fibrillation Undergoing Cardioversion
Biopharmaceuticals Cardiology
 HSMN NewsFeed - 18 Mar 2014
On-X Life Technologies Prepares European Sales Force to Sell On-X(R) Plus 1.5(TM) Aortic Heart Valve
Devices Cardiology Product Launch
 HSMN NewsFeed - 13 Mar 2014
Surefire Medical Receives FDA Clearance, CE Mark For New Line Of Guiding Catheters
Devices Interventional FDA
 HSMN NewsFeed - 11 Mar 2014
AngioDynamics Receives Expanded FDA Clearance for AngioVac
Devices Cardiology FDA
 HSMN NewsFeed - 21 Feb 2014
In a Subanalysis, Eliquis(R) (apixaban) Reduced the Risk of Stroke and Demonstrated Fewer Major Bleeding Events versus Warfarin Consistently across Age Groups, Including Older Patients with Nonvalvular Atrial Fibrillation
Biopharmaceuticals Cardiology
 HSMN NewsFeed - 18 Feb 2014
Claret Medical Announces IDE Approval for U.S. Pivotal Trial of the Sentinel(TM) Cerebral Protection System
Devices Interventional FDA
 HSMN NewsFeed - 10 Feb 2014
Two-Year Results From Phase 3 VISTA Trial of EYLEA(R) (aflibercept) Injection for the Treatment of Diabetic Macular Edema Show Sustained Improvement in Vision
Biopharmaceuticals Ophthalmology
 HSMN NewsFeed - 5 Feb 2014
Reverse Medical(R) Corporation Announces New Patent for the Micro Vascular Plug (MVP(R))
Devices Interventional
 HSMN NewsFeed - 19 Dec 2013
Baxter Receives FDA Approval of FEIBA [Anti-Inhibitor Coagulant Complex] for Prophylactic Treatment of Hemophilia A&B Patients with Inhibitors
Biopharmaceuticals FDA
 HSMN NewsFeed - 18 Dec 2013
Regeneron Announces FDA Acceptance of EYLEA(R) (aflibercept) Injection Supplemental Biologics License Application for Review for Diabetic Macular Edema Indication
Biopharmaceuticals Ophthalmology FDA
 HSMN NewsFeed - 16 Dec 2013
EMD Serono's Redesigned Fertility Pen Available for Distribution in US
Biopharmaceuticals Drug Delivery Product Launch
 HSMN NewsFeed - 2 Dec 2013
InspireMD Appoints Rick Olson as Vice President of Global Sales Operations
Devices Interventional Personnel
 HSMN NewsFeed - 2 Dec 2013
Claret Medical Announces Filing Of US Pivotal IDE Application For The Sentinel(TM) Cerebral Protection System
Devices Interventional Cardiology FDA
 HSMN NewsFeed - 26 Nov 2013
FDA Approves Varithena(TM) (Polidocanol Injectable Foam) for the Treatment of Patients with Varicose Veins
Biopharmaceuticals FDA
 HSMN NewsFeed - 22 Nov 2013
EYLEA(R) (aflibercept) Injection Approved For The Treatment of Macular Edema Following Central Retinal Vein Occlusion In Japan
Biopharmaceuticals Ophthalmology Regulatory
 HSMN NewsFeed - 14 Nov 2013
Long Term Follow Up Data On WEB Aneurysm Embolization System Demonstrate High Rate Of Stable Occlusion In Difficult To Treat Aneurysms
Devices Interventional
 HSMN NewsFeed - 7 Nov 2013
Surefire Medical Closes Series B Funding at $18.2 Million
Devices Oncology Venture Capital
 HSMN NewsFeed - 29 Oct 2013
AngioDynamics Achieves CE Approval for AngioVac
Devices Surgery Cardiology
 HSMN NewsFeed - 18 Oct 2013
Surefire Medical Launches mT Infusion System For Small Vessel Interventional Procedures
Devices Interventional Product Launch
 HSMN NewsFeed - 15 Oct 2013
Pulsar Vascular Receives CE Mark Approval For PulseRider(R)
Devices Interventional Regulatory Product Launch
 HSMN NewsFeed - 8 Oct 2013
Terumo Interventional Systems Launches The Detachable AZUR(R) CX Peripheral Coil System
Devices Interventional Product Launch
 HSMN NewsFeed - 23 Sep 2013
Bayer receives approval for Adempas(R) as first drug to treat rare heart and lung disease
Biopharmaceuticals Regulatory
 HSMN NewsFeed - 17 Sep 2013
Dendreon Announces Marketing Authorization for PROVENGE(R) in the European Union
Biopharmaceuticals Oncology Regulatory
 HSMN NewsFeed - 16 Sep 2013
Surefire Medical's Anti-Reflux Infusion System May Eliminate Coiling, Lower Cost Of Embolization Procedures
Devices Drug Delivery Oncology
 HSMN NewsFeed - 9 Sep 2013
Keystone Heart's TriGuard(TM) Cerebral Protection Device Receives CE Marking
Devices Interventional Cardiology Regulatory
 HSMN NewsFeed - 4 Sep 2013
InspireMD Announces New Appointment to the Board of Directors
Devices Interventional Cardiology Personnel
 HSMN NewsFeed - 3 Sep 2013
Subanalysis of Phase III ARISTOTLE Trial of Eliquis(R) (apixaban) Demonstrated Consistent Results Versus Warfarin in Patients with Nonvalvular Atrial Fibrillation with or without Valvular Heart Disease
Biopharmaceuticals Cardiology
 HSMN NewsFeed - 28 Aug 2013
FDA Accepts Boehringer Ingelheim's Supplemental New Drug Application for Use of Dabigatran Etexilate Mesylate in Deep Vein Thrombosis and Pulmonary Embolism
Biopharmaceuticals FDA
 HSMN NewsFeed - 21 Aug 2013
Reverse Medical Corporation Announces FDA 510k Clearance of the MVP(TM) Micro Vascular Plug for Peripheral Embolization
Devices Interventional FDA Product Launch
 HSMN NewsFeed - 26 Jul 2013
EYLEA(R) (aflibercept) Injection Recommended for Approval for the Treatment of Visual Impairment Due to Macular Edema Secondary to Central Retinal Vein Occlusion in Europe
Biopharmaceuticals Ophthalmology Regulatory
 HSMN NewsFeed - 22 Jul 2013
MicroVention Announces First Trial Enrollment In Their U.S. Clinical Trial Of Its New Dual-Layer Stent For Cerebral Aneurysm Flow Diversion
Devices Interventional Neurology
 HSMN NewsFeed - 18 Jul 2013
Celgene Will Discontinue Phase III ORIGIN(R) Trial in Previously Untreated Elderly Patients with B-Cell Chronic Lymphocytic Leukemia
Biopharmaceuticals Oncology
 HSMN NewsFeed - 1 Jul 2013
Merit Medical Announces Multiple Regulatory Approvals
Devices Interventional FDA Regulatory
 HSMN NewsFeed - 31 May 2013
Oral Anti-Cancer Therapy Pomalidomide Celgene Receives Positive CHMP Opinion as Treatment for Patients with Relapsed and Refractory Multiple Myeloma
Biopharmaceuticals Oncology Regulatory
 HSMN NewsFeed - 24 May 2013
PBAC Approves XIFAXAN(R) (Rifaxamin α) 550 mg Cost Effectiveness in Australia
Biopharmaceuticals Regulatory
 HSMN NewsFeed - 23 May 2013
InspireMD's MGuard Embolic Protection Stent (EPS) Shows Lower Mortality Rate in STEMI Patients at Six Months Compared to Control Group
Devices Interventional Cardiology
 HSMN NewsFeed - 20 May 2013
Sequent Medical, Inc. Launches New SL Family of WEB Aneurysm Embolization Devices
Devices Interventional Radiology Product Launch
 HSMN NewsFeed - 20 May 2013
Claret Medical, Inc. Announces Publication of the First Clinical Research on the Frequency and Composition of Embolic Debris Captured during TAVR
Devices Interventional Cardiology
 HSMN NewsFeed - 16 May 2013
InspireMD Announces Reimbursement Coverage for MGuard(TM) Coronary Embolic Protection Stent
Devices Interventional Cardiology Reimbursement
 HSMN NewsFeed - 7 May 2013
Baxter Announces Topline Results of Phase III Study of Immunoglobulin for Alzheimer's Disease
Biopharmaceuticals Neurology
 HSMN NewsFeed - 10 Apr 2013
Kaleidoscope Medical Secures Series A Funding
Devices Venture Capital
 HSMN NewsFeed - 6 Mar 2013
Study: Surefire Medical's Technology Improves Delivery Of Embolics In Cancer Treatment
Devices Oncology Interventional Drug Delivery
 HSMN NewsFeed - 28 Feb 2013
CSL Behring Receives FDA Approval to Expand the Indication for Corifact(R)
Biopharmaceuticals Surgery FDA
 HSMN NewsFeed - 27 Feb 2013
Claret Medical, Inc. Announces CE Mark Approval of Montage 2(TM) and Live Case Debut During JIM 2013
Devices Interventional Regulatory
 HSMN NewsFeed - 26 Feb 2013
Surefire Medical Receives CE Mark Approval for Next Generation Infusion System and Specialty Catheters
Devices Interventional Regulatory
 HSMN NewsFeed - 19 Feb 2013
Regeneron and Bayer Initiate Phase 3 Trial of EYLEA(R) (aflibercept) Injection for the Treatment of Diabetic Macular Edema in Asia and Russia
Biopharmaceuticals Ophthalmology
 HSMN NewsFeed - 13 Feb 2013
Loma Vista Medical Reports That It is Ramping up Sales in U.S. and Europe of its FDA-Cleared and CE-Marked TRUE Dilatation(TM) Balloon Valvuloplasty Catheter Specifically Designed to Reduce ‘Rapid Pacing’ Time and Prevent Balloon Failure
Devices Interventional Cardiology Distribution
 HSMN NewsFeed - 11 Feb 2013
Bayer Submits New Drug Application for Riociguat for the Treatment of Pulmonary Arterial Hypertension and Persistent/Recurrent Chronic Thromboembolic Pulmonary Hypertension
Biopharmaceuticals
 HSMN NewsFeed - 5 Feb 2013
ZALTRAP(R) (ziv-aflibercept) Approved in the EU for Patients with Previously Treated Metastatic Colorectal Cancer
Biopharmaceuticals Oncology Regulatory
 HSMN NewsFeed - 4 Jan 2013
InspireMD Names Alan Milinazzo President and CEO
Devices Interventional Cardiology Personnel
 HSMN NewsFeed - 3 Jan 2013
Angioslide Completes $6.3 Million Financing Led by TriVentures
Devices Interventional Venture Capital
 HSMN NewsFeed - 11 Dec 2012
Sequent Medical, Inc. Launches VIA Microcatheter
Devices Neurology Interventional Regulatory
 HSMN NewsFeed - 6 Dec 2012
EYLEA(R) (aflibercept) Submitted for EU Marketing Authorization for the Treatment of Macular Edema Following Central Retinal Vein Occlusion
Biopharmaceuticals Ophthalmology Regulatory
 HSMN NewsFeed - 27 Nov 2012
EYLEA(R) (aflibercept) Injection Approved for the Treatment of Wet Age-Related Macular Degeneration in Europe
Biopharmaceuticals Ophthalmology Regulatory
 HSMN NewsFeed - 22 Oct 2012
On-X Life Technologies Submits for FDA/CE Approval of Reduced Anticoagulation Indication for On-X Aortic Heart Valve
Devices Cardiology FDA Regulatory
 HSMN NewsFeed - 22 Oct 2012
Bayer's Investigational Riociguat Meets Primary Endpoint in Phase III Study in Patients with Pulmonary Arterial Hypertension (PAH)
Biopharmaceuticals
 HSMN NewsFeed - 10 Oct 2012
Surefire Medical Receives FDA Clearance for Angiographic Catheters
Devices Radiology Interventional FDA
 HSMN NewsFeed - 8 Oct 2012
AngioDynamics to Acquire Vortex Medical
Devices Mergers & Acquisitions
 HSMN NewsFeed - 25 Sep 2012
InspireMD Announces CEO Transition as it Sets Commercialization Plan for Advanced Stent Technology
Devices Interventional Cardiology Personnel
 HSMN NewsFeed - 17 Sep 2012
Pfizer To Present New Data in Lung And Kidney Cancers at The European Society For Medical Oncology 2012 Congress
Biopharmaceuticals Oncology
 HSMN NewsFeed - 5 Sep 2012
Penumbra, Inc. Receives Shonin Approval for the Penumbra Coil 400(TM) in Japan To Treat Intracranial Aneurysms
Devices Interventional Regulatory
 HSMN NewsFeed - 5 Sep 2012
Surefire Medical's Infusion System For Embolization Procedures Receives CE Mark Approval
Devices Interventional Regulatory
 HSMN NewsFeed - 4 Sep 2012
Pfizer Receives EU Marketing Authorization for INLYTA(R) (Axitinib)
Biopharmaceuticals Oncology Regulatory
 HSMN NewsFeed - 18 Jul 2012
Teleflex Acquires Hotspur Technologies, Inc.
Devices Interventional Mergers & Acquisitions
 HSMN NewsFeed - 25 Jun 2012
Baxter Announces FDA Approval for GAMMAGARD LIQUID as a Treatment for Multifocal Motor Neuropathy
Biopharmaceuticals Neurology FDA
 HSMN NewsFeed - 25 Jun 2012
Bristol-Myers Squibb and Pfizer Receive Complete Response Letter from U.S. Food and Drug Administration for ELIQUIS(R) (apixaban)
Biopharmaceuticals Cardiology FDA
 HSMN NewsFeed - 21 Jun 2012
Surefire Medical Receives FDA Clearance For High-Flow Microcatheter
Devices Interventional FDA
 HSMN NewsFeed - 18 Jun 2012
St. Jude Medical Announces FDA Clearance of the AMPLATZER Vascular Plug 4
Devices Interventional FDA
 HSMN NewsFeed - 5 Jun 2012
Asher Holzer Retires as President of InspireMD
Devices Interventional Cardiology Personnel
 HSMN NewsFeed - 23 May 2012
The On-X(R) Heart Valve Compares Favorably to Tissue Valves
Devices Cardiology
 HSMN NewsFeed - 2 May 2012
Angioslide Announces FDA 510(K) Clearance of PROTEUS(TM) Below The Knee Device
Devices Interventional FDA
 HSMN NewsFeed - 27 Apr 2012
Baxter Presents Efficacy and Safety Data Evaluating GAMMAGARD LIQUID for Multifocal Motor Neuropathy at AAN Annual Meeting
Biopharmaceuticals Neurology
 HSMN NewsFeed - 24 Apr 2012
Nordion Announces Europe-Focused Phase III Clinical Trial for TheraSphere(R) Liver Cancer Treatment
Devices Oncology
 HSMN NewsFeed - 15 Mar 2012
CSL Behring Announces First Patient Treated in Phase III Study of Fibrinogen Concentrate (Human)(FCH) to Control Bleeding During Aortic Aneurysm Surgery
Biopharmaceuticals Surgery
 HSMN NewsFeed - 8 Mar 2012
Regeneron and Bayer Announce Approval of EYLEA(R) (aflibercept) Injection for the Treatment of Wet Age-Related Macular Degeneration in Australia
Biopharmaceuticals Ophthalmology Regulatory
 HSMN NewsFeed - 30 Jan 2012
Baxter Announces FDA Approval of Expanded Indication for TISSEEL [Fibrin Sealant] for General Hemostasis in Surgery
Devices Surgery FDA
 HSMN NewsFeed - 13 Dec 2011
Edoxaban Significantly Reduces Risk of Venous Thromboembolism by Half Compared to Enoxaparin in Japanese and Taiwanese Patients Following Knee or Hip Arthroplasty Surgery
Biopharmaceuticals
 HSMN NewsFeed - 6 Dec 2011
Amgen and FDA Agree to Modify Nplate(R) (Romiplostim) Risk Evaluation and Mitigation Strategy
Biopharmaceuticals FDA
 HSMN NewsFeed - 1 Dec 2011
Covidien's Embolic Protection Device Receives FDA Clearance
Devices Interventional FDA
 HSMN NewsFeed - 9 Nov 2011
Merck Launches NEXPLANON(R) (etonogestrel implant) 68 mg in the United States – A Long-Acting Reversible Hormonal Contraceptive Effective For Up to Three Years
Biopharmaceuticals Drug Delivery
 HSMN NewsFeed - 1 Nov 2011
Boston Scientific Announces Schedule of Events at TCT Scientific Symposium
Devices Interventional Cardiology
 HSMN NewsFeed - 25 Oct 2011
Lilly Announces Withdrawal of Xigris(R) Following Recent Clinical Trial Results
Biopharmaceuticals
 HSMN NewsFeed - 8 Sep 2011
Angioslide Announces the European Launch of New 300 mm Long Device Allowing Treatment of Entire Superficial Femoral Artery(SFA) with One Device
Devices Interventional
 HSMN NewsFeed - 31 Aug 2011
Baxter Announces FDA Approval of ARTISS Fibrin Sealant for Use in Face-Lift (Facial Rhytidectomy) Procedures
Devices FDA
 HSMN NewsFeed - 26 Aug 2011
Boehringer Ingelheim to Launch RE-ALIGN Trial to Evaluate Dabigatran Etexilate in Patients with Mechanical Heart Valves
Biopharmaceuticals Cardiology
 HSMN NewsFeed - 25 Jul 2011
Baxter Announces FDA Approval of Subcutaneous Route of Administration for GAMMAGARD LIQUID for Patients with Primary Immunodeficiency
Biopharmaceuticals FDA
 HSMN NewsFeed - 13 Jul 2011
InfraReDx Initiates a Randomized Clinical Trial of LipiScan IVUS™ Coronary Imaging Guidance to Prevent Heart Attacks During Stenting
Devices Interventional Cardiology
 HSMN NewsFeed - 12 Jul 2011
Boston Scientific Completes Clinical Trial Enrollment for Adapt Monorail Carotid Stent System
Devices Interventional
 HSMN NewsFeed - 1 Jul 2011
Merck Receives Approval to Market GARDASIL(R), ZOLINZA(R) and CUBICIN(R) in Japan
Biopharmaceuticals Regulatory
 HSMN NewsFeed - 31 May 2011
Final Published Trial Data in The Lancet Supports Safety and Effectiveness of MicroVention-Terumo's HydroCoil(R) Embolic System for Treatment of Cerebral Aneurysms
Devices Interventional
 HSMN NewsFeed - 20 May 2011
ELIQUIS(R) (apixaban) Approved In Europe For Preventing Venous Thromboembolism After Elective Hip Or Knee Replacement
Biopharmaceuticals Surgery Orthopaedic
 HSMN NewsFeed - 28 Apr 2011
Straub Medical AG receives class-III CE-mark-approval for Rotarex(R)S and Aspirex(R)S endovascular catheter families
Devices Interventional Regulatory
 HSMN NewsFeed - 22 Apr 2011
Daiichi Sankyo Receives First Market Approval in Japan for LIXIANA(R) (edoxaban), a Direct Oral Factor Xa Inhibitor, for the Prevention of Venous Thromboembolism after Major Orthopedic Surgery
Biopharmaceuticals Surgery Regulatory
 HSMN NewsFeed - 28 Mar 2011
Cantata(TM) Superselective Microcatheter Broadens Cook Medical’s Line of Embolization Products
Devices Interventional Radiology
 HSMN NewsFeed - 8 Mar 2011
Medtronic CareLink(R) Network Remote Monitoring Helps Improve Patient Care and Reduce Healthcare Costs
Devices Cardiology Monitoring
 HSMN NewsFeed - 25 Feb 2011
FDA Grants Full Approval for PROMACTA(R) (eltrombopag) for Treatment of Rare Blood Disorder
Biopharmaceuticals FDA
 HSMN NewsFeed - 4 Feb 2011
FDA Approves Makena, the First and Only Treatment to Reduce the Risk of Preterm Birth in Women With a Singleton Pregnancy Who Have a History of Singleton Spontaneous Preterm Birth
Biopharmaceuticals FDA
 HSMN NewsFeed - 31 Jan 2011
Boston Scientific Announces FDA Approval of Renegade(R) HI-FLO Fathom(R) Pre-Loaded System
Devices Interventional Drug Delivery Oncology FDA
 HSMN NewsFeed - 22 Dec 2010
Newly Published Investigational Apixaban ADVANCE-3 Study Results Demonstrate Statistical Superiority to Enoxaparin with Comparable Rates of Bleeding in the Prevention of Venous Thromboembolism Following Total Hip Replacement Surgery
Biopharmaceuticals Orthopaedic Surgery
 HSMN NewsFeed - 14 Dec 2010
Large Canadian Heart Valve Study Provides Evidence of On-X(R) Heart Valve Superior Performance
Devices Cardiology
 HSMN NewsFeed - 6 Dec 2010
PROCHIEVE 8% Vaginal Progesterone Gel Achieves Primary Endpoint in Phase III Study to Reduce Risk of Preterm Birth
Biopharmaceuticals
 HSMN NewsFeed - 25 Oct 2010
Medtronic Launches Improved Delivery System in Canada for Minimally Invasive Treatment of Thoracic Aortic Aneurysms
Devices Interventional
 HSMN NewsFeed - 26 Aug 2010
NMT Medical Announces Changes in Management and Board of Directors
Devices Interventional Cardiology Personnel
 HSMN NewsFeed - 20 Aug 2010
REVLIMID(R) Approved for Treatment of Deletion 5q Myelodysplastic Syndromes in Japan
Biopharmaceuticals Oncology Regulatory
 HSMN NewsFeed - 3 Aug 2010
Final Data in International Trial Supports Safety and Effectiveness of MicroVention-Terumo's HydroCoil(R) Embolic System for Treatment of Cerebral Aneurysms
Devices Interventional
 HSMN NewsFeed - 30 Jul 2010
Hotspur Technologies Receives FDA 510(k) Clearance for First Three Product Lines Based on the Company's Unique Technology
Devices FDA
 HSMN NewsFeed - 16 Jul 2010
GTC Biotherapeutics Regains US Rights to ATryn(R) ; the First Recombinant Antithrombin Product Approved in the World
Biopharmaceuticals
 HSMN NewsFeed - 1 Jul 2010
FDA Approves Sagent Pharmaceuticals' Heparin Sodium Injection, USP
Biopharmaceuticals FDA
 HSMN NewsFeed - 17 Jun 2010
Micrus Endovascular Receives Approval to Market DeltaPaq and DeltaPlush Microcoils in Japan
Devices Interventional Neurology Regulatory
 HSMN NewsFeed - 1 Jun 2010
Covidien Announces Definitive Agreement to Acquire ev3 Inc.
Devices Mergers & Acquisitions Interventional
 HSMN NewsFeed - 26 May 2010
The New England Journal of Medicine Publishes Results of Landmark CREST Study, Showing Similar Positive Outcomes for Abbott's Carotid Stent System and Surgery
Devices Interventional
 HSMN NewsFeed - 26 May 2010
For the First Time, at EuroPCR, InspireMD Will Provide a Sneak Preview of the Next Generation MGuard Prime(R), a State of the Art Net Protective Cobalt Chromium Stent System
Devices Interventional Cardiology
 HSMN NewsFeed - 19 May 2010
Embrella Cardiovascular, Inc. Receives European CE Mark Approval for the Embrella Embolic Deflector Device
Devices Interventional Regulatory
 HSMN NewsFeed - 19 May 2010
NMT Medical Appoints Paul H. Kramer, MD, to Board of Directors
Devices Interventional Cardiology Personnel
 HSMN NewsFeed - 18 May 2010
ev3 Inc. Files PMA Application for FDA Approval of Pipeline Embolization Device
Devices Interventional Neurology FDA
 HSMN NewsFeed - 10 May 2010
Ferring Acquires LYSTEDA(TM) From Xanodyne Pharmaceuticals, Inc.
Biopharmaceuticals Acquisitions
 HSMN NewsFeed - 7 May 2010
U.S. FDA Approves Natazia(TM), a New Oral Contraceptive for the Prevention of Pregnancy
Biopharmaceuticals FDA
 HSMN NewsFeed - 23 Apr 2010
Merz Aesthetics Announces FDA Approval of Asclera(TM) (Polidocanol) Injection, First Sclerosant to Treat Small Varicose Veins in 60 Years
Biopharmaceuticals FDA
 HSMN NewsFeed - 21 Apr 2010
Medtronic Completes Acquisition of Invatec and Affiliated Companies
Devices Cardiology Mergers & Acquisitions
 HSMN NewsFeed - 6 Apr 2010
Baxter and Nycomed Announce FDA Approval of TachoSil(R)
Devices Surgery FDA
 HSMN NewsFeed - 4 Mar 2010
Watson Announces Agreement to Acquire U.S. Rights to Columbia Laboratories' CRINONE(R) Progesterone Gel Product Line
Biopharmaceuticals Acquisitions
 HSMN NewsFeed - 3 Mar 2010
NMT Medical Appoints John E. Ahern to Board of Directors
Devices Interventional Cardiology Personnel
 HSMN NewsFeed - 16 Feb 2010
Centocor Ortho Biotech Products and Amgen Finalize ESA Risk Evaluation and Mitigation Strategy (REMS) With FDA
Biopharmaceuticals Oncology FDA
 HSMN NewsFeed - 9 Feb 2010
Volcano Corporation Completes Acquisition of Lumen Biomedical's Xtract(TM) Thrombus Aspiration Catheter
Devices Interventional Cardiology Acquisitions
 HSMN NewsFeed - 13 Jan 2010
Octapharma Receives Orphan Drug Exclusivity Approval for wilate(R) - A Replacement Therapy Developed Specifically for von Willebrand Disease
Biopharmaceuticals FDA
 HSMN NewsFeed - 6 Jan 2010
ev3 Announces Completion of Voluntary Recall
Devices Interventional Product Recall
 HSMN NewsFeed - 5 Jan 2010
Embrella Cardiovascular, Inc. Completes Successful First Clinical Experience
Devices Interventional
 HSMN NewsFeed - 23 Oct 2009
Invatec Receives FDA Clearance for Mo.Ma(R) Ultra Proximal Cerebral Protection Device
Devices Interventional FDA
 HSMN NewsFeed - 6 Oct 2009
SurModics Enters Ophthalmic License and Development Agreement with Roche and Genentech
Biopharmaceuticals Ophthalmology Drug Delivery Licensing
 HSMN NewsFeed - 6 Oct 2009
Scientific Paper Supports Micro-Bland Embolization Technique for Liver Cancer With Embozene(TM) Microspheres
Devices Oncology
 HSMN NewsFeed - 23 Sep 2009
InspireMD Announces the Enrollment of the 1st Patient in the MGuard(TM) Israeli Registry
Devices Interventional Cardiology
 HSMN NewsFeed - 21 Sep 2009
Invatec Announces the Worldwide Launch of FiberNet®, the Smallest Distal Embolic Protection System on the Market, at CIRSE 2009
Devices Interventional
 HSMN NewsFeed - 16 Sep 2009
New Micro-Bland Embolization Technique with Embozene(TM) Microspheres to Be Presented at the International Medical Conference in Lisbon, Portugal
Devices Oncology
 HSMN NewsFeed - 15 Sep 2009
Wyeth Presents Data from Five-Year Vertebral Fracture Prevention Study with Bazedoxifene
Biopharmaceuticals
 HSMN NewsFeed - 24 Aug 2009
Micrus Endovascular Signs Licensing and Development Agreement for Flow Diversion Technology
Devices Neurology Interventional
 HSMN NewsFeed - 20 Aug 2009
Angiotech Pharmaceuticals announces the commercial launch of the Option(TM) Inferior Vena Cava Filter in the United States
Devices Interventional
 HSMN NewsFeed - 18 Aug 2009
Avastin Plus Commonly Used Chemotherapies Improved Progression-Free Survival (PFS) in Women with Previously Treated Advanced Breast Cancer
Biopharmaceuticals Oncology
 HSMN NewsFeed - 14 Aug 2009
Embrella Cardiovascular, Inc. Announces Final Closing of Series B Round
Devices Interventional Venture Capital
 HSMN NewsFeed - 3 Aug 2009
FDA Approves Avastin for the Most Common Type of Kidney Cancer
Biopharmaceuticals Oncology FDA
 HSMN NewsFeed - 30 Jul 2009
Second Phase III Study Showed Lucentis Improved Vision in Patients With Retinal Vein Occlusion
Biopharmaceuticals Ophthalmology
 HSMN NewsFeed - 15 Jul 2009
Spectranetics Announces First Human Uses of Turbo-Tandem System
Devices Interventional
 HSMN NewsFeed - 24 Jun 2009
NMT Medical Appoints Chief Operating Officer Richard E. Davis to Board of Directors
Devices Interventional Cardiology Personnel
 HSMN NewsFeed - 12 Jun 2009
Abbott Announces Launch of Next-Generation Embolic Protection System
Devices Interventional
 HSMN NewsFeed - 11 Jun 2009
4 Top Transplant Hospitals Honored as "Best of the Best" for Total Artificial Heart
Devices Cardiology
 HSMN NewsFeed - 8 Jun 2009
Angiotech Pharmaceuticals announces FDA 510(k) clearance of the Option(TM) Inferior Vena Cava Filter
Devices Interventional FDA
 HSMN NewsFeed - 5 May 2009
FDA Grants Accelerated Approval of Avastin for Brain Cancer (Glioblastoma) That Has Progressed Following Prior Therapy
Biopharmaceuticals Oncology FDA
 HSMN NewsFeed - 16 Apr 2009
BioSphere Medical Enters into Exclusive Distribution Agreement with Nippon Kayaku for Japanese Market
Devices Distribution
 HSMN NewsFeed - 14 Apr 2009
NMT Medical Appoints Frank Martin Permanent President & CEO
Devices Cardiology Personnel
 HSMN NewsFeed - 9 Apr 2009
NMT Medical Receives PMA Approval for STARFlex as a Ventricular Septal Defect Repair Implant
Devices Interventional Cardiology FDA
 HSMN NewsFeed - 7 Apr 2009
Study Data Show Positive European Experience With DuraHeart Left Ventricular Assist Device for Advanced Stage Heart Failure Patients
Devices Cardiology
 HSMN NewsFeed - 1 Apr 2009
Abbott Initiates U.S. Study of Absolute Pro(TM) Peripheral Stent System for Iliac Artery Disease
Devices Interventional
 HSMN NewsFeed - 31 Mar 2009
Boehringer Ingelheim Plans to Launch U.S. Registry to Assess the State of Anticoagulation Therapy for Stroke Prevention in Patients with Non-Valvular Atrial Fibrillation
Biopharmaceuticals Cardiology
 HSMN NewsFeed - 26 Mar 2009
Atritech Completes $30 Million Financing
Devices Cardiology Venture Capital
 HSMN NewsFeed - 24 Mar 2009
Abbott Advances Its Revolutionary Fully Bioabsorbable Drug Eluting Stent With Initiation of Next Phase of Clinical Trial
Devices Interventional Cardiology
 HSMN NewsFeed - 20 Mar 2009
Final Patient Completes Treatment In Boehringer Ingelheim's RE-LY(R) Study, The Largest Atrial Fibrillation Outcomes Trial To Date
Biopharmaceuticals Cardiology
 HSMN NewsFeed - 16 Mar 2009
CytRx's Arimoclomol Demonstrates Statistically Significant Neurorestorative Results in a Preclinical Embolic Stroke Trial
Biopharmaceuticals Neurology
 HSMN NewsFeed - 12 Mar 2009
ULORIC(R) (febuxostat) 40-mg and 80-mg Tablets Now Available for the Chronic Management of Hyperuricemia in Patients with Gout
Biopharmaceuticals
 HSMN NewsFeed - 11 Mar 2009
CSL Behring Receives Orphan-Drug Exclusivity for RiaSTAP(TM), First and Only Approved Treatment of Acute Bleeding Episodes in Patients with Congenital Fibrinogen Deficiency
Biopharmaceuticals FDA
 HSMN NewsFeed - 10 Mar 2009
Gore Announces First Patient Treated With Recently-Cleared GORE Flow Reversal System
Devices Interventional
 HSMN NewsFeed - 14 Feb 2009
FDA Approves ULORIC(R) (febuxostat) for the Chronic Management of Hyperuricemia in Patients with Gout
Biopharmaceuticals FDA
 HSMN NewsFeed - 10 Feb 2009
NMT Medical Appoints Board Member Frank Martin Interim President & Chief Executive Officer
Devices Interventional Cardiology Neurology Personnel
 HSMN NewsFeed - 9 Feb 2009
GORE Flow Reversal System Cleared by FDA
Devices Interventional Neurology FDA
 HSMN NewsFeed - 17 Jan 2009
CSL Behring Receives FDA Approval of RiaSTAP(TM), First and Only Approved Treatment of Acute Bleeding Episodes in Patients with Congenital Fibrinogen Deficiency
Biopharmaceuticals FDA
 HSMN NewsFeed - 14 Jan 2009
Merit Medical Announces Microcatheter Market Entry
Devices Interventional
 HSMN NewsFeed - 1 Jan 2009
First U.S. Implants of Newly Approved Embozene(TM) Color-Advanced Microspheres Embolization Platform
Devices Interventional Oncology
 HSMN NewsFeed - 18 Dec 2008
Boston Scientific Initiates Carotid Stent Clinical Study
Devices Interventional
 HSMN NewsFeed - 18 Dec 2008
First Lung Lesion and First Lymph Node Metastasis Treated With AngioDynamics’ IRE Technology at Australia’s The Alfred Hospital
Devices Oncology
 HSMN NewsFeed - 16 Dec 2008
CeloNova BioSciences Receives FDA Market Approval for Embozene(TM) Color-Advanced Microspheres Embolization Platform
Devices Interventional FDA
 HSMN NewsFeed - 9 Dec 2008
ev3 Inc. Receives FDA Clearance to Market EverCross and NanoCross Peripheral Angioplasty Balloons
Devices Interventional FDA
 HSMN NewsFeed - 8 Dec 2008
MGuard(TM) Coronary Stent System Approved in Israel
Devices Interventional Cardiology Regulatory
 HSMN NewsFeed - 23 Nov 2008
Avastin Plus Commonly Used Chemotherapies Demonstrated Improved Progression-Free Survival In Advanced Breast Cancer
Biopharmaceuticals Oncology
 HSMN NewsFeed - 10 Oct 2008
W. L. Gore & Associates Receives FDA Approval for Gore EMBOLDEN Clinical Study
Devices FDA Interventional
 HSMN NewsFeed - 8 Oct 2008
Lumen Biomedical Receives FDA Clearance of Embolectomy System for Treatment of Peripheral Artery Disease
Devices Interventional FDA
 HSMN NewsFeed - 7 Oct 2008
CeloNova BioSciences to Showcase the CE-Marked CATANIA(TM) Coronary Stent System Featuring NanoThin Polyzene(R)-F at TCT Debut
Devices Interventional Cardiology
 HSMN NewsFeed - 24 Sep 2008
Nice Approves Pradaxa(R)*(Dabigatran Etexilate) - First New Oral Anticoagulant in the UK for Over 50 Years
Biopharmaceuticals Regulatory
 HSMN NewsFeed - 16 Sep 2008
Micrus Endovascular Launches Neuropath Guide Catheter
Devices Neurology Interventional
 HSMN NewsFeed - 12 Sep 2008
OmniSonics Medical Technologies Announces Licensing and Development Agreement with Boston Scientific
Devices Interventional Licensing
 HSMN NewsFeed - 2 Sep 2008
New Data is Presented on Investigational Oral Anticoagulant Apixaban in Acute Coronary Syndrome Patients
Biopharmaceuticals Cardiology
 HSMN NewsFeed - 22 Aug 2008
FDA Approves Nplate(TM) for Long-Term Treatment of Adult Chronic ITP
Biopharmaceuticals FDA
 HSMN NewsFeed - 29 Jul 2008
Chest Physicians Now Suggest Early Intervention for Certain Blood Clots in DVT
Devices Interventional
 HSMN NewsFeed - 21 Jul 2008
ev3 Inc. Announces Promotion of Pascal E.R. Girin to Lead Global Neurovascular Business and International
Devices Personnel
 HSMN NewsFeed - 10 Jul 2008
Micrus Endovascular Receives Approval to Market Cerecyte Microcoils in Japan
Devices Regulatory Neurology Interventional
 HSMN NewsFeed - 8 Jul 2008
Longitude Capital Closes $325 Million Life Sciences Fund
Venture Capital
 HSMN NewsFeed - 23 Jun 2008
Micrus Endovascular Announces CE Mark for PHAROS Vitesse Stent
Devices Neurology Interventional Regulatory
 HSMN NewsFeed - 5 Jun 2008
Positive Clinical Data Evaluating the Micrus Endovascular Cerecyte Microcoil Published in Peer-Reviewed Journals
Devices Neurosurgery Interventional
 HSMN NewsFeed - 2 Jun 2008
Angioslide Closes US$8.6million Series C Financing
Devices Interventional Venture Capital
 HSMN NewsFeed - 19 May 2008
NMT Medical Announces Settlement of Damages Claims in Patent Infringement Lawsuit with Cardia
Devices Litigation
 HSMN NewsFeed - 19 May 2008
Boston Scientific Announces Launch of Expanded Size Range of FilterWire EZ(TM) Embolic Protection System
Devices Interventional
 HSMN NewsFeed - 5 May 2008
Gore Receives Approval From FDA For Unique Patent Foramen Ovale Stroke Study
Devices Cardiology FDA
 HSMN NewsFeed - 24 Apr 2008
Lannett Company Receives Approval for Dipyridamole Tablets USP, 25 mg, 50 mg, and 75 mg
Biopharmaceuticals Generics FDA
 HSMN NewsFeed - 23 Apr 2008
Micrus Endovascular and Chemence Medical Products Sign Development Agreement for Liquid Embolic Products
Devices Neurology Interventional
 HSMN NewsFeed - 21 Apr 2008
Genentech Provides Update on ''AVAiL'' Phase III Study of Avastin Plus Chemotherapy in First-Line, Advanced, Non-Squamous, Non-Small Cell Lung Cancer
Biopharmaceuticals Oncology
 HSMN NewsFeed - 17 Apr 2008
Medtronic Announces CE Mark and European Launch of New 'Defender' Embolic Protection Filter
Devices Interventional Regulatory
 HSMN NewsFeed - 14 Apr 2008
KV Begins Shipping Evamist(TM) to Wholesalers
Biopharmaceuticals
 HSMN NewsFeed - 7 Apr 2008
Robert Palmisano Appointed President, Chief Executive Officer and Director of ev3 Inc.
Devices Interventional Personnel
 HSMN NewsFeed - 28 Mar 2008
BioSphere Medical Commences Sales of Embosphere(R) Microspheres in the People's Republic of China
Devices Interventional
 HSMN NewsFeed - 27 Mar 2008
Novel Oral Anticoagulant Pradaxa(R) (dabigatran etexilate) Approved by the European Commission
Biopharmaceuticals Regulatory
 HSMN NewsFeed - 20 Mar 2008
Baxter Announces FDA Approval of ARTISS Slow-Setting Fibrin Sealant in Treatment of Burn Patients
Devices FDA
 HSMN NewsFeed - 13 Mar 2008
Amgen to Discuss Benefits and Risks of ESA Treatment for Cancer Patients with Anemia Due to Chemotherapy at FDA ODAC Meeting
Biopharmaceuticals Oncology FDA
 HSMN NewsFeed - 11 Mar 2008
Totality of Available Data Reaffirms PROCRIT(R) (Epoetin alfa) Is Safe and Effective When Used Appropriately as Labeled to Treat Chemotherapy-Induced Anemia
Biopharmaceuticals FDA
 HSMN NewsFeed - 8 Mar 2008
Ortho Biotech Modifies Prescribing Information for PROCRIT(R) (Epoetin alfa)
Biopharmaceuticals
 HSMN NewsFeed - 7 Mar 2008
Amgen Announces Update to U.S. Prescribing Information for Aranesp(R) and EPOGEN(R)
Biopharmaceuticals FDA
 HSMN NewsFeed - 7 Mar 2008
Embrella Cardiovascular, Inc. Hires Carol Burns as Vice President of Product & Business Development
Devices Interventional Personnel
 HSMN NewsFeed - 6 Mar 2008
InnerPulse, Inc. Appoints Elsa Chi Abruzzo as Vice-President of Regulatory and Quality Affairs
Devices Personnel
 HSMN NewsFeed - 5 Mar 2008
Iverson Genetic Diagnostics Offers FDA Cleared Warfarin Test
Diagnostics FDA
 HSMN NewsFeed - 5 Mar 2008
EU Commission Approves Updated Prescribing Information for Aranesp(R)
Biopharmaceuticals Regulatory
 HSMN NewsFeed - 25 Feb 2008
GTx's Toremifene Citrate 80 mg Meets Primary and Key Endpoints in Phase III Trial in Advanced Prostate Cancer Patients on Androgen Deprivation Therapy
Biopharmaceuticals Oncology
 HSMN NewsFeed - 23 Feb 2008
FDA Grants Accelerated Approval of Avastin in Combination With Paclitaxel Chemotherapy for First-Line Treatment of Advanced HER2-Negative Breast Cancer
Biopharmaceuticals Oncology FDA
 HSMN NewsFeed - 8 Feb 2008
ev3 Inc. Accepts Resignation of Dr. John Simpson
Devices Interventional Personnel
 HSMN NewsFeed - 30 Jan 2008
NMT Medical Announces Separation of Chairman and Chief Executive Officer Roles
Devices Interventional Cardiology Personnel
 HSMN NewsFeed - 28 Jan 2008
BioSphere Medical Receives Market Clearance to Sell Embosphere(R) Microspheres in the People's Republic of China
Devices Regulatory
 HSMN NewsFeed - 28 Jan 2008
Clexane(R)/Lovenox(R) Approved in Japan
Biopharmaceuticals Regulatory
 HSMN NewsFeed - 23 Jan 2008
NMT Medical Announces Significant Changes to Its Clinical Trial Plans in the United States
Devices Interventional Cardiology
 HSMN NewsFeed - 17 Jan 2008
Micrus Endovascular and Genesis Medical Interventional Sign License, Development and Commercialization Agreement
Devices Interventional Neurology Licensing
 HSMN NewsFeed - 15 Jan 2008
Study Published in the Journal of Vascular and Interventional Radiology Concludes That Embosphere(R) Microspheres Should Be the Preferred Agent for Uterine Fibroid Embolization When Compared to Boston Scientific's Contour SE(TM) PVA Microspheres
Devices Interventional
 HSMN NewsFeed - 12 Dec 2007
WorldHeart Announces Strategic Alliance With Abiomed
Devices Cardiology
 HSMN NewsFeed - 7 Dec 2007
Amgen in Discussions with FDA to Update U.S. Prescribing Information for ESAs
Biopharmaceuticals
 HSMN NewsFeed - 6 Dec 2007
Micrus Endovascular Receives Approval to Market Stretch-Resistant Microcoils in Japan
Devices Neurology Interventional Regulatory
 HSMN NewsFeed - 5 Dec 2007
Genentech Provides Update from Avastin FDA Advisory Meeting
Biopharmaceuticals Oncology FDA
 HSMN NewsFeed - 21 Nov 2007
MIV Therapeutics to Sell Israeli Subsidiary SagaX
Devices Interventional
 HSMN NewsFeed - 18 Nov 2007
Avastin Shows Encouraging Results in Phase II Study in Patients With the Most Aggressive Form of Brain Cancer
Biopharmaceuticals Oncology
 HSMN NewsFeed - 9 Nov 2007
HealthTrust Purchasing Group and Bracco Diagnostics Inc. Sign Three-Year Agreement for X-Ray Contrast Media
Biopharmaceuticals Radiology Group Purchasing
 HSMN NewsFeed - 9 Nov 2007
NMT Medical Wins Favorable Ruling in Patent Infringement Lawsuit Against Cardia
Devices Interventional Cardiology Litigation
 HSMN NewsFeed - 8 Nov 2007
Ortho Biotech to Submit Official Request for Reconsideration to CMS Regarding ESA Coverage Policy
Biopharmaceuticals Reimbursement
 HSMN NewsFeed - 8 Nov 2007
Amgen Announces Updates to the U.S. Prescribing Information for ESAs
Biopharmaceuticals FDA
 HSMN NewsFeed - 8 Nov 2007
Micrus Endovascular Names Gordon Sangster Chief Financial Officer
Devices Personnel
 HSMN NewsFeed - 5 Nov 2007
Micrus Endovascular to Divest $3 Million in Non-Core Cardiac and Peripheral Assets to Merit Medical Systems
Devices Interventional
 HSMN NewsFeed - 31 Oct 2007
ev3 Inc. Announces Agreements in Principle to Settle Patent Litigation
Devices Interventional Litigation
 HSMN NewsFeed - 25 Oct 2007
Minnesota Based Lumen Biomedical Goes Global with Innovative Products for Patients with Vascular Disease
Devices Interventional
 HSMN NewsFeed - 23 Oct 2007
Boston Scientific Carotid Artery Stenting Trials Produce Positive Three-Year Results
Devices Interventional
 HSMN NewsFeed - 23 Oct 2007
Real-World Studies of Carotid Artery Stenting Demonstrate Results Comparable to Guidelines for Patients Treated With Surgery
Devices Interventional
 HSMN NewsFeed - 23 Oct 2007
Roche Considering Legal Options In Patent Litigation Case
Biopharmaceuticals Litigation
 HSMN NewsFeed - 23 Oct 2007
Medtronic Trials Confirm Ability of Interceptor(R) Coronary Filter System and Export(R) Aspiration Catheter to Reduce Major Cardiac Events
Devices Interventional Cardiology
 HSMN NewsFeed - 22 Oct 2007
InspireMD's MGuard(TM) Coronary Stent Receives CE Mark
Devices Interventional Cardiology Regulatory
 HSMN NewsFeed - 19 Oct 2007
NMT Medical Appoints James J. Mahoney, Jr., to Board of Directors
Devices Interventional Cardiology Personnel
 HSMN NewsFeed - 19 Oct 2007
Pivotal MIRCERA(R) Study First to Convert Dialysis Patients From Frequent Dosing Directly to Once Every Two Weeks or Once Every Four Weeks
Biopharmaceuticals
 HSMN NewsFeed - 4 Oct 2007
ev3 and FoxHollow Technologies Announce Completion of Merger
Devices Interventional Mergers & Acquisitions
 HSMN NewsFeed - 2 Oct 2007
Duramed Launches New Indication for ENJUVIA(TM) (Synthetic Conjugated Estrogens, B) at North American Menopause Society Annual Meeting
Biopharmaceuticals
 HSMN NewsFeed - 27 Sep 2007
Amgen Receives Proposal for Amending EU Prescribing Information for Aranesp(R)
Biopharmaceuticals Regulatory
 HSMN NewsFeed - 25 Sep 2007
Abbott Initiates Clinical Study to Evaluate Use of RX Herculink(R) Elite(TM) Renal Stent System for the Treatment of Renal Artery Stenosis
Devices Interventional
 HSMN NewsFeed - 25 Sep 2007
Aranesp(R) DAHANCA 10 Study Results Presented at ECCO Annual Meeting
Biopharmaceuticals Oncology
 HSMN NewsFeed - 24 Sep 2007
Micrus Endovascular Board of Directors Names CEO John Kilcoyne Chairman and Promotes Robert Stern to President
Devices Personnel
 HSMN NewsFeed - 19 Sep 2007
Wyeth Presents Phase 3 Fracture Data for Bazedoxifene, an Investigational Therapy for Osteoporosis
Biopharmaceuticals
 HSMN NewsFeed - 11 Sep 2007
Ortho Biotech Supports FDA Advisory Committees' Recommendations on Use of ESAs in Chronic Renal Failure Patients
Biopharmaceuticals
 HSMN NewsFeed - 11 Sep 2007
Ortho Biotech Reiterates Confidence in PROCRIT(R) (Epoetin alfa) Safety and Efficacy When Used According to Label
Biopharmaceuticals
 HSMN NewsFeed - 10 Sep 2007
BioVascular, Inc. Merges with Revitus and Acquires First-In-Class Platelet Count Reducer
Biopharmaceuticals Cardiology Mergers & Acquisitions
 HSMN NewsFeed - 6 Sep 2007
Aranesp(R) Study Showing No Negative Impact on Survival in SCLC Presented at World Conference on Lung Cancer
Biopharmaceuticals Oncology
 HSMN NewsFeed - 5 Sep 2007
Results from Study Evaluating PROCRIT(R) in Intensive Care Unit Patients Published in New England Journal of Medicine
Biopharmaceuticals
 HSMN NewsFeed - 4 Sep 2007
Oral Cancer Drug REVLIMID(R) Receives Swissmedic Approval in Switzerland for Treatment of Multiple Myeloma
Biopharmaceuticals Regulatory Oncology
 HSMN NewsFeed - 24 Aug 2007
Genentech Announces Resubmission of Supplemental Biologics License Application for Avastin in Combination with Paclitaxel for First-Line Metastatic Breast Cancer
Biopharmaceuticals Oncology
 HSMN NewsFeed - 15 Aug 2007
Merit Medical Announces Exclusive Distribution Deal for Microcatheter
Devices Distribution Interventional
 HSMN NewsFeed - 14 Aug 2007
InspireMD Received Pre-launch Orders for its MGuard(TM) Coronary Stent
Devices Interventional Cardiology
 HSMN NewsFeed - 2 Aug 2007
ev3 Inc. Awarded Contracts by Novation
Devices Interventional Group Purchasing
 HSMN NewsFeed - 1 Aug 2007
Micrus Endovascular Signs Distribution Agreement to Enter Chinese Market
Devices Interventional Neurology Distribution
 HSMN NewsFeed - 31 Jul 2007
Micrus Endovascular Signs Letter of Intent to Acquire Revascularization Technology to Treat Ischemic Stroke
Devices Interventional Neurology
 HSMN NewsFeed - 25 Jul 2007
NMT Medical Announces the Commercial Launch of BioSTAR(R) in Europe and Canada
Devices Interventional Cardiology
 HSMN NewsFeed - 25 Jul 2007
St. Jude Medical Announces FDA Clearance of the Proxis Embolic Protection System
Devices Interventional Cardiology FDA
 HSMN NewsFeed - 23 Jul 2007
ev3 And FoxHollow To Merge In Transaction Creating A Global Leader In Endovascular Device Market
Devices Interventional Mergers & Acquisitions
 HSMN NewsFeed - 20 Jul 2007
Journal of Clinical Oncology Publishes Data on ZOLINZA(TM) (vorinostat), Merck's Treatment for Advanced Cutaneous T-cell Lymphoma
Biopharmaceuticals Oncology
 HSMN NewsFeed - 13 Jul 2007
NMT Medical Appoints David L. West, Ph.D., MPH to Board of Directors
Devices Cardiology Personnel
 HSMN NewsFeed - 11 Jul 2007
Phase 3 Results for Dabigatran Etexilate, an Investigational Oral Anticoagulant, Presented Today at the XXIst Congress of the International Society on Thrombosis and Haemostasis
Biopharmaceuticals
 HSMN NewsFeed - 10 Jul 2007
Kensey Nash to Exit Embolic Protection Markets
Devices Interventional
 HSMN NewsFeed - 8 Jul 2007
Phase III Trial Results Show Superiority of Rivaroxaban over Enoxaparin for the Prevention of Venous Thromboembolism in Patients Undergoing Knee Replacement Surgery
Biopharmaceuticals
 HSMN NewsFeed - 28 Jun 2007
NMT Medical Receives CE Mark Approval for BioSTAR(R)
Devices Interventional Cardiology Regulatory
 HSMN NewsFeed - 26 Jun 2007
EKOS Appoints Robert Hubert as President and Chief Executive Officer
Devices Drug Delivery Personnel
 HSMN NewsFeed - 20 Jun 2007
Baxter Signs Agreements to Evaluate TISSEEL Use With New, Innovative Therapies
Devices Regenerative Medicine
 HSMN NewsFeed - 19 Jun 2007
REVLIMID(R) Granted Full Marketing Authorization for Treatment of Multiple Myeloma in the European Union
Biopharmaceuticals Oncology Regulatory
 HSMN NewsFeed - 18 Jun 2007
NMT Medical's BioSTAR(R) Receives Canadian Regulatory Approval
Devices Interventional Cardiology Regulatory
 HSMN NewsFeed - 18 Jun 2007
Kensey Nash Announces Results of EU Coronary Study Using the Thromcat(TM) Thrombectomy Catheter System
Devices Interventional Cardiology
 HSMN NewsFeed - 13 Jun 2007
Bradley Pharmaceuticals Announces Launch of Elestrin(TM)
Biopharmaceuticals
 HSMN NewsFeed - 6 Jun 2007
NMT Medical Wins Favorable Ruling in Patent Infringement Lawsuit Against Cardia
Devices Interventional Cardiology Litigation
 HSMN NewsFeed - 4 Jun 2007
Soliris(TM) Effective in PNH Patients With History of Aplastic Anemia and Myelodysplastic Syndromes
Biopharmaceuticals Oncology
 HSMN NewsFeed - 4 Jun 2007
EntreMed Presents Phase 2 Results for Panzem(R) Capsules in Multiple Myeloma
Biopharmaceuticals Oncology
 HSMN NewsFeed - 3 Jun 2007
VELCADE(R) (Bortezomib) for Injection Based Therapy Substantially Improves Event-Free Survival and Complete Response Rate in Newly Diagnosed Multiple Myeloma Patients
Biopharmaceuticals Oncology
 HSMN NewsFeed - 2 Jun 2007
Phase III Study Shows Avastin Plus Interferon Therapy Nearly Doubled Median Progression-Free Survival in Patients With Previously Untreated Advanced Kidney Cancer
Biopharmaceuticals Oncology
 HSMN NewsFeed - 2 Jun 2007
Second Phase III Study of Avastin Plus Chemotherapy Shows Improved Progression-Free Survival in First-Line Non-Squamous, Non-Small Cell Lung Cancer
Biopharmaceuticals Oncology
 HSMN NewsFeed - 1 Jun 2007
Kensey Nash Announces Acquisition of Assets of MacroPore Biosurgery Business Unit from Cytori Therapeutics
Devices Orthopaedic Neurosurgery Acquisitions
 HSMN NewsFeed - 31 May 2007
First Patient Enrolled in SONOMA Post-Market Approval Study of Boston Scientific NexStent(R) Carotid Stent System and FilterWire EZ(TM) Embolic Protection Device
Devices Interventional
 HSMN NewsFeed - 29 May 2007
Micrus Endovascular Receives FDA Clearance for the ENZO Steerable Microcatheter
Devices Neurology Interventional FDA
 HSMN NewsFeed - 22 May 2007
FDA Approves Lybrel, First Low Dose Combination Oral Contraceptive Offering Women the Opportunity to Be Period-Free Over Time
Biopharmaceuticals FDA
 HSMN NewsFeed - 22 May 2007
InspireMD Announces Enrollment of 19 Patients in its First in Man Study
Devices Interventional Cardiology
 HSMN NewsFeed - 18 May 2007
FDA Approves Lovenox(R) (Enoxaparin Sodium Injection) for the Most Severe Type of Heart Attack
Biopharmaceuticals Cardiology FDA
 HSMN NewsFeed - 15 May 2007
SWOG Phase III Newly Diagnosed Multiple Myeloma Trial (S0232) Closed and Patients Given Choice to Switch to REVLIMID(R) Plus Dexamethasone
Biopharmaceuticals Oncology
 HSMN NewsFeed - 10 May 2007
Rex Medical Announces the Successful Retrieval of the Option(TM) Vena Cava Filter up to Day 225 in an International Clinical Study
Devices
 HSMN NewsFeed - 9 May 2007
New Device Granted Humanitarian Exemption to Treat Intracranial Aneurysms
Devices FDA Neurology Interventional
 HSMN NewsFeed - 7 May 2007
Bayer HealthCare and Intendis Announce Strategic Alliance to Co-Promote Yaz(R) (Drospirenone/Ethinyl Estradiol) for Treatment of Moderate Acne
Biopharmaceuticals Dermatology
 HSMN NewsFeed - 4 May 2007
Micrus Endovascular Launches Cashmere Microcoil System to Treat Complex Cerebral Aneurysms
Devices Neurology Interventional
 HSMN NewsFeed - 2 May 2007
FDA Approves FRAGMIN(R) as First Low-Molecular-Weight Heparin for Extended Treatment to Reduce the Recurrence of Blood Clots in Patients with Cancer
Biopharmaceuticals FDA
 HSMN NewsFeed - 30 Apr 2007
Humate-P(R) Approved to Prevent Excessive Bleeding in Patients with von Willebrand Disease Undergoing Surgery
Biopharmaceuticals FDA
 HSMN NewsFeed - 30 Apr 2007
Duramed's ENJUVIA(TM) (Synthetic Conjugated Estrogens, B) Tablets Receives Two New FDA Approvals
Biopharmaceuticals FDA
 HSMN NewsFeed - 23 Apr 2007
NMT Medical Receives FDA Approval for Modifications in Pivotal U.S. PFO/Stroke Trial
Devices FDA Interventional Cardiology Neurology
 HSMN NewsFeed - 19 Apr 2007
Aranesp(R) ``145 Study'' Shows No Difference in Survival in Patients with Small-Cell Lung Cancer
Biopharmaceuticals Oncology
 HSMN NewsFeed - 16 Apr 2007
Aranesp(R) Phase 3 Study in Patients with Active Cancer Not Receiving Concurrent Chemotherapy or Radiotherapy Presented at AACR Annual Meeting
Biopharmaceuticals Oncology
 HSMN NewsFeed - 16 Apr 2007
ev3's Onyx HD 500 Receives HDE Approval from FDA for Treatment of Cerebral Aneurysms
Devices Interventional Neurology FDA
 HSMN NewsFeed - 10 Apr 2007
Kensey Nash Receives Expanded CE Mark Approval for TriActiv(R) ProGuard(TM) Embolic Protection System in Carotid Anatomy
Devices Interventional Regulatory
 HSMN NewsFeed - 5 Apr 2007
Final Patient Enrolled In International Trial of MicroVention's HydroCoil(R) Embolic System
Devices Interventional
 HSMN NewsFeed - 4 Apr 2007
Portola Pharmaceuticals Announces Positive Phase II Results for PRT054021 for Prevention of Venous Thromboembolism Following Total Knee Replacement Surgery
Biopharmaceuticals
 HSMN NewsFeed - 4 Apr 2007
ECOG Phase III Newly Diagnosed Multiple Myeloma Trial (E4A03) Reports LENALIDOMIDE Plus Low-Dose Dexamethasone Suggests Survival Advantage for Patients with Multiple Myeloma
Biopharmaceuticals Oncology
 HSMN NewsFeed - 3 Apr 2007
ev3 Inc. and Volcano Corporation Announce Joint Marketing and Distribution Agreement
Devices Interventional Distribution
 HSMN NewsFeed - 31 Mar 2007
Baxter Announces FDA Approval Of Ceprotin For Severe Congential Protein C Deficiency
Biopharmaceuticals FDA
 HSMN NewsFeed - 29 Mar 2007
Proteo, Inc./Proteo Biotech AG: European Commission grants Orphan Drug Status to Elafin for the treatment of PAH
Biopharmaceuticals Regulatory
 HSMN NewsFeed - 26 Mar 2007
Two Abbott Studies Reaffirm Carotid Artery Stenting as a Safe and Effective Treatment to Reduce Risk of Stroke
Devices Interventional
 HSMN NewsFeed - 26 Mar 2007
Bosentan -- Tracleer -- Receives Positive EU Opinion for Reduction of New Digital Ulcerations in Systemic Sclerosis Patients
Biopharmaceuticals
 HSMN NewsFeed - 23 Mar 2007
Oral Cancer Drug REVLIMID(R) Receives Positive Opinion for Treatment of Multiple Myeloma From European Medicines Agency
Biopharmaceuticals Oncology Regulatory
 HSMN NewsFeed - 22 Mar 2007
Cook Medical Introduces the MiraFlex(TM) Microcatheter
Devices Interventional
 HSMN NewsFeed - 21 Mar 2007
Biomet and Kensey Nash Announce Exclusive Marketing and Distribution Agreement for OrthoFill(TM) Proprietary Bone Void Filler
Devices Orthopaedic Distribution
 HSMN NewsFeed - 9 Mar 2007
Ortho Biotech Revises Prescribing Information for PROCRIT(R) (Epoetin alfa)
Biopharmaceuticals Oncology FDA
 HSMN NewsFeed - 9 Mar 2007
Amgen Announces Update To U.S. Prescribing Information for Aranesp(R) and EPOGEN(R)
Biopharmaceuticals Oncology FDA
 HSMN NewsFeed - 7 Mar 2007
Novation Signs New Technology Agreement With ev3 Inc.
Devices Interventional Group Purchasing
 HSMN NewsFeed - 5 Mar 2007
Actelion: Positive Study With Bosentan (Tracleer) in CTEPH
Biopharmaceuticals
 HSMN NewsFeed - 22 Feb 2007
Analysis of International Phase III Study of Avastin(R) Plus Chemotherapy Shows Improved Progression-Free Survival in Patients With Advanced Lung Cancer
Biopharmaceuticals Oncology
 HSMN NewsFeed - 19 Feb 2007
Rex Medical Announces the Successful Retrieval of the Option(TM) Vena Cava Filter from a Femoral Approach In Vivo
Devices Interventional
 HSMN NewsFeed - 15 Feb 2007
New Version of Devices to Treat Clogged Neck Arteries Approved by U.S. Food and Drug Administration
Devices Interventional FDA
 HSMN NewsFeed - 7 Feb 2007
FDA Grants Priority Review to Lovenox(R) (Enoxaparin Sodium Injection) Supplemental New Drug Application (sNDA) for Acute Heart Attack
Biopharmaceuticals Cardiology
 HSMN NewsFeed - 4 Feb 2007
Phase III Trial of Progesterone for the Prevention of Preterm Birth in Women with a Previous Preterm Birth Earlier than 35 Weeks Does Not Meet Endpoints
Biopharmaceuticals
 HSMN NewsFeed - 1 Feb 2007
Grifols Announces FDA Approval of Alphanate(R) to Treat von Willebrand Disease
Biopharmaceuticals FDA
 HSMN NewsFeed - 29 Jan 2007
FDA Approves New Indication for YAZ(R) to Treat Acne
Biopharmaceuticals Dermatology FDA
 HSMN NewsFeed - 24 Jan 2007
ev3 Inc. Announces US FDA Approval of PROTEGE(R) RX Carotid Stent
Devices Interventional FDA
 HSMN NewsFeed - 18 Jan 2007
Rex Medical Announces the Successful Clinical Retrieval of the Option(TM) Vena Cava Filter Up To Day 107 in an International Clinical Study
Devices
 HSMN NewsFeed - 12 Jan 2007
AngioDynamics and RITA Medical Systems Announce Expiration of Hart-Scott-Rodino Waiting Period for RITA Medical Systems Acquisition
Devices Mergers & Acquisitions
 HSMN NewsFeed - 8 Jan 2007
ev3 Inc. and FoxHollow Technologies, Inc. Announce a Clinical Collaboration and Distribution Agreement for SpideRX(R) and RockHawk(R) Technologies
Devices Interventional Distribution
 HSMN NewsFeed - 8 Jan 2007
FoxHollow Technologies Provides Update on Corporate Strategy; Announces Preliminary Fourth Quarter 2006 Revenue of $44.7 Million
Devices Interventional
 HSMN NewsFeed - 4 Jan 2007
Boston Scientific Acquires EndoTex Interventional Systems, Inc.
Devices Interventional Mergers & Acquisitions
 HSMN NewsFeed - 28 Dec 2006
SciClone Submits Regulatory Application for DC Bead in China
Biopharmaceuticals Drug Delivery Oncology Regulatory
 HSMN NewsFeed - 20 Dec 2006
Gore Announces First Use of GORE Embolic Liquid to Occlude Cerebral Arteriovenous Malformation at Oregon Health & Science University
Devices Neurosurgery Interventional
 HSMN NewsFeed - 18 Dec 2006
Successful Study With Tracleer(r) in Patients With Mildly Symptomatic Pulmonary Arterial Hypertension
Biopharmaceuticals
 HSMN NewsFeed - 14 Dec 2006
FilterWire EZ(TM) Embolic Protection System Cleared By FDA For Carotid Artery Stenting
Devices Interventional FDA
 HSMN NewsFeed - 14 Dec 2006
GenVec Announces Completion of Interim Safety Data Analysis for Phase II/III Trial with TNFerade(TM) in Pancreatic Cancer
Biopharmaceuticals Oncology
 HSMN NewsFeed - 13 Dec 2006
New England Journal of Medicine Publishes Data from Pivotal Study of Avastin Plus Chemotherapy in Most Common Type of Lung Cancer
Biopharmaceuticals Oncology
 HSMN NewsFeed - 12 Dec 2006
Rex Medical Announces the Successful Clinical Retrieval of the Option(TM) Vena Cava Filter in an International Clinical Study
Devices Interventional
 HSMN NewsFeed - 12 Dec 2006
Interim Analysis of Phase III Trial Shows Avastin Plus Interferon Therapy Improved Progression-Free Survival in Patients With Previously Untreated Advanced Renal Cell Carcinoma
Biopharmaceuticals Oncology
 HSMN NewsFeed - 11 Dec 2006
Positive Phase 3 Results for New Fixed Oral Dose Anticoagulant Presented at 48th Annual Meeting of the American Society of Hematology
Biopharmaceuticals
 HSMN NewsFeed - 8 Dec 2006
49 Abstracts Evaluating Revlimid(R) To Be Presented at The 48th American Society of Hematology Meeting
Biopharmaceuticals Oncology
 HSMN NewsFeed - 1 Dec 2006
Micrus Endovascular Acquires Catheter Technology Company VasCon LLC
Devices Mergers & Acquisitions
 HSMN NewsFeed - 30 Nov 2006
RITA Medical Systems Announces Market Release of Habib 4X Laparoscopic(TM)
Devices Surgery
 HSMN NewsFeed - 29 Nov 2006
Micrus Endovascular Announces Positive Results from Prospective Cerecyte Study
Devices Neurology Interventional
 HSMN NewsFeed - 28 Nov 2006
AngioDynamics to Acquire RITA Medical for $220 Million
Devices Mergers & Acquisitions
 HSMN NewsFeed - 20 Nov 2006
Actelion Announces Definitive Agreement to Acquire U.S.-Based CoTherix, Inc.
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 14 Nov 2006
Kensey Nash Announces Commencement of Carotid Pivotal Trial for TriActiv ProGuard System
Devices Interventional
 HSMN NewsFeed - 9 Nov 2006
BioSphere Medical Receives FDA Approval For QuadraSphere(TM) Microspheres
Devices Interventional FDA
 HSMN NewsFeed - 6 Nov 2006
New Low Profile Optional Vena Cava Filter Receives Conditional FDA Approval to Begin U.S. Clinical Trial
Devices FDA
 HSMN NewsFeed - 3 Nov 2006
Boston Scientific Announces FDA Approval of NexStent(R) Carotid Artery Stenting System
Devices Interventional FDA Mergers & Acquisitions
 HSMN NewsFeed - 31 Oct 2006
The Latest Head-to-Head Clinical Study Comparing the Risk of CIN between Two Contrast Agents Used in CE-MDCT Examinations Was Published in Investigative Radiology
Biopharmaceuticals Radiology
 HSMN NewsFeed - 26 Oct 2006
RITA Medical Initiates Feasibility Study of Device for RFA-Assisted Breast Lumpectomy
Devices Oncology
 HSMN NewsFeed - 23 Oct 2006
Boston Scientific Reports Positive Results for its Carotid Artery Stenting Trial
Devices Interventional
 HSMN NewsFeed - 23 Oct 2006
Kensey Nash Receives CE Mark Approval for New ThromCat(TM) Thrombectomy Catheter System
Devices Interventional
 HSMN NewsFeed - 18 Oct 2006
Genesis Medical Interventional to Launch F.A.S.T.(TM) Funnel Catheter(TM) at Upcoming TCT Meeting October 23 in Washington, DC.
Devices Interventional Cardiology
Return to NewsFeed  

 Additional items found! 317

Members: click here for search results from The HSMN Archive (password required)
Members Archive contains 317 additional stories matching:
embolic
(Password required)
FindReps - screen and connect with rep candidates anonymously, in real time.

FindReps: Screen and connect with Medical Sales Rep candidates (Direct Reps and Independents) – anonymously, in real time.


RepJobs - Job Opportunities for Direct Sales Reps and New Product Lines for Independents!

RepJobs: Job Opportunities for Direct Sales Reps and New Product Lines for Independents!